Profile
AADI NVO VRTX REGN MRNA SGEN
Company Name Aadi Bioscience, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $35.11M $579.91B $126.85B $115.26B $46.43B $43.15B
Employees 0.08K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. David J. Lennon Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
AADI NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 4 4 3 3
Quant Rating Sell Strong Buy Buy Buy Neutral Neutral
Trading
AADI NVO VRTX REGN MRNA SGEN
Last Close $1.43 $131.54 $491.57 $1063.6 $121.14 $228.74
High 52 $7.13 $199.54 $492.13 $1100.05 $166.61 $228.9
Low 52 $1.32 $87.78 $340.48 $727.13 $69.51 $191.57
Price vs. 52 Week High -79.94 % -34.08 % -0.11 % -3.31 % -27.29 % -0.07 %
Price vs. 52 Week Low 8.33 % 49.85 % 44.38 % 46.27 % 74.28 % 19.4 %
Total Return
AADI NVO VRTX REGN MRNA SGEN
1 Month Return -15.38 % -7.34 % 4.88 % 0.99 % -9.19 % 0 %
3 Month Return -24.74 % 5.01 % 22.92 % 18.16 % 15.97 % 0 %
6 Month Return -14.88 % 24.69 % 11.69 % 12.81 % 21.5 % 0 %
9 Month Return -65.04 % 36.61 % 35.85 % 31.56 % 50.67 % 6.14 %
YTD Return -29.21 % 27.15 % 20.81 % 21.1 % 21.81 % 0 %
1 Year Return -75.97 % -20.6 % 35.62 % 44.78 % -4.18 % 17.51 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AADI NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.15 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -17.36 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
AADI NVO VRTX REGN MRNA SGEN
Asset Growth -28.12 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth 55.21 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth 60.06 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year -98.9 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year -89.85 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth -22.01 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -15.36 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 88.09 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 46.84 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -16012.19 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth -22.01 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -20.19 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 97.04 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 13.68 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -16214.56 % 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 3.56 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 3.56 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -44.45 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 105.33 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -84.93 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 5776.52 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 322.88 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -27.06 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
AADI NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM 87.7 % 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -61.97 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -61.83 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -81.82 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 92.24 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -313 % 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -838.24 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 4.83 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.95 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM 0.49 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM 352.51 % 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 21.46 % 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -2.15 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -2.27 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 327.16 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -243.31 % 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.76 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -838.24 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -0.57 78.98 36.46 29 -12.64 -61.54
Price To Operating Cash Flows Ratio TTM -0.67 43.03 32.18 24.19 -16.06 -79.67
Price Cash Flow Ratio TTM -0.67 43.03 32.18 24.19 -16.06 -79.67
Income Statement (TTM)
AADI NVO VRTX REGN MRNA SGEN
Revenue $0.02B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $0.02B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 88.47% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.07B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.07B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -2.44 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
AADI NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.11B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.05B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.01B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.13B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
AADI NVO VRTX REGN MRNA SGEN
Net Income $-0.07B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $-0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
ABCL AbCellera Biologics Inc. 2.97
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.11
ABIO ARCA biopharma, Inc. 3.285
ABOS Acumen Pharmaceuticals, Inc. 2.87
ABSI Absci Corporation 3.97
ABUS Arbutus Biopharma Corporation 3.69
ABVC ABVC BioPharma, Inc. 0.826
ABVX Abivax SA American Depositary Shares 12.4
ACAD ACADIA Pharmaceuticals Inc. 17.75
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.24
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.8352
ACHV Achieve Life Sciences, Inc. 4.63
ACIU AC Immune SA 3.48
ACLX Arcellx, Inc. 62.56
ACRV Acrivon Therapeutics, Inc. Common Stock 7.33
ACST Acasti Pharma Inc. 2.84
ACXP Acurx Pharmaceuticals, Inc. 2.43
ETFs With Exposure to AADI
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00002 216.8
VTI Vanguard Total Stock Market Index Fund 0 271.06
XBI SPDR S&P Biotech ETF 0.05 97.51
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 120.37
IWN iShares Russell 2000 Value ETF 0.00004 164.67
LABU Direxion Daily S&P Biotech Bull 3X Shares 0.01 129.71
IWO iShares Russell 2000 Growth ETF 0.00934 277.24
VXF Vanguard Extended Market Index Fund 0 175.3
HDG ProShares Hedge Replication ETF 0.000190685 49.6546
UWM ProShares Ultra Russell2000 0.000380553 42.19
IWC iShares Micro-Cap ETF 0.00674 123.586
URTY ProShares UltraPro Russell2000 0.000180747 51.94
VTWV Vanguard Russell 2000 Value Index Fund 0 145.03
BTEC Principal Healthcare Innovators ETF 0.0272886 38.6671
SBIO ALPS Medical Breakthroughs ETF 0.0009 36.4147
VFLQ Vanguard U.S. Liquidity Factor ETF 0.09 99.7611
VTWO Vanguard Russell 2000 Index Fund 0 87.63
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 93.93
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 93.91
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.97
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47.96
VBINX Vanguard Balanced Index Fund Investor Shares 0 47.97
RYLD Global X Russell 2000 Covered Call ETF 0 16.14
DFAU Dimensional US Core Equity Market ETF 0.000457 38
DFAT Dimensional U.S. Targeted Value ETF 0.00010085 54.77
DFAS Dimensional U.S. Small Cap ETF 0.00015816 63.16
VTSAX Vanguard Total Stock Market Index Fund 0 131.88
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.99
VITSX Vanguard Total Stock Market Index Fund 0 131.9
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000729842 93.14
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 133
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00112634 35.31
TYNE Direxion Nanotechnology ETF 0.453966 17.2638
AVSC Avantis U.S. Small Cap Equity ETF 0.01 53.77
DCOR Dimensional ETF Trust 0.00000627 60.5589
VEMPX Vanguard Extended Market Index InstlPlus 0 328.19
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 247.41
RSSL Global X Funds 0 85.17
Unlock